Specific sputum markers, including higher sputum eosinophils, macrophages, and lymphocyte counts, were associated with remission after interleukin-5 (IL-5)–targeted therapy for patients with severe ...

The phase 3 EXHALE-4 study demonstrated that dexpramipexole, an oral small molecule therapy, significantly improved ...

Initial Series A raise of $350 million funding Areteia Phase III development program of dexpramipexole in eosinophilic asthma, including three ongoing Phase III clinical trials Additional funding of ...

AstraZeneca experienced some setbacks last year on its quest to expand its asthma drug Fasenra to treat other conditions like rhinosinusitis and eosinophilic esophagitis. However, the British pharma ...

Please provide your email address to receive an email when new articles are posted on . Clinical remission meant no exacerbations, no maintenance oral corticosteroid use and well-controlled asthma. A ...

March 9, 2009 — The anti-interleukin-5 monoclonal antibody mepolizumab may be helpful in refractory eosinophilic asthma, according to the results of 2 studies reported in the March 5 issue of the New ...

"With regard to the prevalence of comorbidities, the burden associated with severe [non-eosinophilic] asthma was heavy due to more comorbidities. Allergic asthma is as frequent in [eosinophilic] as in ...

The available treatments for eosinophilic asthma come with a wide range of side effect risks. Areteia Therapeutics is developing an oral therapy designed to match the blockbuster biologic drugs that ...

CHAPEL HILL, N.C.--(BUSINESS WIRE)--Areteia Therapeutics announced today that the first patients have been dosed in both the EXHALE-2 and EXHALE-4 trials as part of its overall Phase III clinical ...

Some people with very severe asthma symptoms have a condition called eosinophilic asthma. People with this type of asthma may need to use inhaled medicines along with a newer type of medicine that is ...

Please provide your email address to receive an email when new articles are posted on . Eosinophilic asthma was defined as 300 cells/µL and higher. ICU stays were slightly but not significantly longer ...

Eosinophilic asthma (e-asthma) is a rare form of the breathing disease that can be very hard to treat successfully. That can put you in a frustrating cycle of asthma attacks. People with e-asthma are ...